Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0%	61.3	$
CMSC	-0.09%	22.046	$
GSK	1.54%	51.89	$
NGG	0.71%	83.42	$
BTI	1.74%	62.48	$
BCE	0%	23.2	$
CMSD	-0.41%	21.93	$
RIO	1.14%	95.11	$
RYCEF	-0.89%	18	$
BP	-0.37%	37.72	$
RELX	-0.74%	30.92	$
BCC	2.63%	79.76	$
AZN	1.43%	185.68	$
JRI	0.08%	12.58	$
VOD	0.36%	13.86	$

Featured

Quake-hit Venezuela's hospitals care for children left alone

Teenager Yenderlin Cabarza waited alone in an emergency room on Thursday, her bones broken by two powerful earthquakes that devastated Venezuela the day before.

Venezuela mounts desperate search for survivors after twin quakes kill at least 188

Desperate Venezuelans battled Thursday to rescue loved ones trapped alive beneath the rubble of collapsed buildings after two major earthquakes that killed at least 188 people.

Last news

Pakistani sculptor turns scrap into colossal metal artworks

Sparks fly and metal groans in a cavernous workshop on the outskirts of Islamabad, where Pakistani artist Ehtisham Jadoon fuses discarded car parts into colossal pieces inspired by "Transformers" movies and dinosaurs.

Hillary Clinton to testify in US House panel's Epstein probe

Former US secretary of state Hillary Clinton is to testify behind closed doors Thursday before a congressional committee investigating the late convicted sex offender Jeffrey Epstein and his accomplice Ghislaine Maxwell.

David's Bridal Enters Entertainment Arena With Launch of Original Series

BREAKING BRIDAL -- Real Weddings. Zero Rules.Spotlighting How Modern Couples Are Rewriting Traditions & Breaking the Wedding Mold, David's New Documentary-Style Series blends culture, content, & commerce; Shifting from Legacy Retailer to Wedding Entertainment Powerhouse

NHI Announces The First Quarter 2026 Dividend

MURFREESBORO, TN / ACCESS Newswire / February 26, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $0.92 per common share on May 1, 2026, to stockholders of record as of March 31, 2026.

Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

SAN DIEGO, CA / ACCESS Newswire / February 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, today reported its financial results for the three and twelve months ended December 31, 2025.

NHI Announces Fourth Quarter 2025 Results

MURFREESBORO, TN / ACCESS Newswire / February 26, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the fourth quarter and year ended December 31, 2025.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

Net revenues of $183.1 million and $719.9 million, respectively, for the three months and fiscal year ended December 31, 2025GAAP net income of $24.4 million, or $0.51 per share and $98.1 million, or $2.03 per share, respectively, for the fourth quarter and fiscal yearAdjusted non-GAAP net income of $34.2 million, or $0.73 per share and $156.6 million, or $3.25 per share, respectively, for the fourth quarter and fiscal yearCompany to hold a conference call today at 2:00 p.m. Pacific Time

RF Industries to Report First Quarter Results on March 16

SAN DIEGO, CA / ACCESS Newswire / February 26, 2026 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced that it will release its first quarter fiscal year 2026 financial results after the close of the market on Monday, March 16, 2026.

Get a Little Out There With Alex Honnold Premieres on the Outside Network Thursday, February 26, 2026

The five-part series marks Alex Honnold's first role hosting a travel show

Cactus Unveils Three Unique Millionaire for Life Campaigns for Colorado Lottery, North Carolina Education Lottery and the Hoosier Lottery

Cactus Demonstrates Strategy, Creative and Media Prowess by Developing and LaunchingThree Distinctive Campaigns for the Same Product

Stemtech Corporation Launches New Market Channel Biosciences Ecommerce

NAPLES, FL / ACCESS Newswire / February 26, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, launches Stemtech BioSciences E-Commerce Retail market channel.

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

With 20g of clean protein, 5g of creatine, and LactoSpore® probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition for modern living.

Black Book Research Releases "France: State of Acute Care EHR and Digital Health 2026"

France country extract from the 2026 Black Book of Global Digital Healthcare IT highlights procurement "proof points" shaping hospital DPI/EHR modernization through 2030: interoperability execution, Ségur-linked timing, GHT governance, regulated hosting (HDS), and cyber-resilience contracting

Karviva and Founder Dr. Angela Zeng Recognized by Missouri Agriculture as Brand Gains National Editorial Attention and Expands Retail Footprint

SAINT LOUIS, MI / ACCESS Newswire / February 26, 2026 / Karviva, the functional beverage company founded by nutritional scientist Dr. Angela Zeng, continues to gain momentum across retail and industry platforms, following recognition from the Missouri Department of Agriculture and its recent selection as one of RangeMe's Top 50 Brands in Food and Beverage. The milestones reflect growing demand for Karviva's science-backed wellness drinks and increasing interest from major retailers nationwide.

Dr. Angela Zeng's TEDx Talk on Supporting Children's Mental Health Without Medication Goes Live

SAINT LOUIS, MISSOURI / ACCESS Newswire / February 26, 2026 / Dr. Angela Zeng, scientist, entrepreneur, and founder of Karviva Wellness Beverages, has released her TEDx talk titled How to Support Your Child's Mental Health Without Medication, now officially live on YouTube. The talk, delivered at TEDxForbesParkSalon, has already surpassed 200,000 views since its publication on January 20, 2026.

Truly Good Foods Unveils Golden Hour(TM) Snack Bars

A Nut-Free, 110-Calorie Bar Designed for Today's On-the-Go Consumers

Forecast Change for The 2025/2026 Fiscal Year

DORTMUND, DE / ACCESS Newswire / February 26, 2026 / Following its elimination from the UEFA-Champions League play-offs yesterday evening and the resulting loss of planned earnings from this competition, Borussia Dortmund is now revising its earnings forecast published in the group management report as of June 30, 2025 to a consolidated net loss of between EUR -12,000 thousand and EUR -22,000 thousand (previously between EUR -5,000 thousand and EUR 5,000 thousand).

InterContinental Hotels Group PLC Announces Transaction in Own Shares - February 26

LONDON, UK / ACCESS Newswire / February 26, 2026 / The Company announces that on 25 February 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Scam centres 'destroying' Cambodia's economy, PM tells AFP

Cambodia's Prime Minister Hun Manet said on Wednesday that scam centres were destroying his country's economy and giving the nation a bad name -- pushing back on allegations of government connivance.

18 Egyptians missing after deadly boat capsize near Greece

Egypt said Wednesday that 18 of its citizens were still missing after a migrant boat capsized, killing four people, off the Greek island of Crete last week.

Bill Gates admits affairs but denies involvement in Epstein crimes

Bill Gates has admitted making a "huge mistake" in associating with Jeffrey Epstein, telling staff at his charity foundation that he had affairs with two Russian women but denying involvement in the disgraced financier's crimes.

Pope lines up trips to Central Africa, Algeria, Spain, Monaco

Pope Leo XIV will visit four African nations in April, the Vatican said Thursday, including Algeria -- the first time a pope will travel to the North African Muslim nation.

Australian police arrest two over alleged kidnapping, murder of grandfather

Australian detectives arrested two men Wednesday over the alleged kidnapping and murder of an elderly grandfather in a suspected case of mistaken identity.

Months after floods, Indonesian survivors frustrated by slow response

Normally, Indonesian mother-of-four Rauzah would cook a feast for her family to break their Ramadan fast. This year, she makes do as best she can in the orange tent where they have been sheltering for almost three months.

Canadians are choosing when to die, often with a smile

Jacques Poissant's suffering stopped the day he asked his daughter if it would be "cowardly to ask to be helped to die".

CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

(This release updates the release that posted earlier on February 25, 2026 to update the sub headlines.)NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this yearCompany expects to opt-out of the 50:50 profit and loss sharing arrangement for rusfertide with Takeda during a 90-day window expected to open in Q2U.S. regulatory decision for ICOTYDETM (icotrokinra) anticipated in 2026 with potential launch this yearPN-881 Phase 1 completion expected by mid-2026Pre-clinical pipeline expanded with novel wholly-owned candidates PN-477, an oral and s.c. triple GLP-GIP-GCG agonist and PN-458, an oral and s.c. dual GLP-GIP agonist, and PN-8047, an oral hepcidin functional mimeticCash, cash equivalents and marketable securities of $646 million as of December 31, 2025, anticipated to provide cash runway through at least end of 2028

Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this yearCompany expects to opt-out of the 50:50 profit and loss sharing arrangement for rusfertide with Takeda during a 90-day window expected to open in Q2U.S. regulatory decision for ICOTYDETM (icotrokinra) anticipated in 2026 with potential launch this yearPN-881 Phase 1 completion expected by mid-2026

DirectTrust and CARIN Alliance Announce CARIN-CFA Accreditation Recognized by CMS as Evaluation Pathway for Participation in the Medicare App Library

Independent accreditation strengthens consumer trust in digital health applications and may support participation in CMS' Medicare App Library

VRCCO Invests in the Future of Veterinary Medicine Through Education-Driven Innovation

BEND, OREGON / ACCESS Newswire / February 25, 2026 / As the veterinary profession faces increasing demands, rapid medical advances, and nationwide workforce shortages, the Veterinary Referral Center of Central Oregon (VRCCO) is taking a proactive approach by strengthening the future of veterinary medicine through continuous education and hands-on professional development.

CBMJ Announces Launch of "Conservative Playbook" Podcast, Expanding Patriot.TV's High‑Growth Media Portfolio Ahead of Midterms

Navigating Contrasting Messaging by legacy media from Disney (DIS), Paramount Global (PARA), Comcast (CMCSA), Warner Bros. Discovery (WBD), and Newsmax (NMAX), Sinclair (SBGI), and Fox Corp. (FOX), Patriot.TV Provides Accurate Narrative regarding Elections.

Dolphin Expands Miami Footprint to Support Continued Growth Across Subsidiaries

Coral Gables office expansion accommodates team growth at The Digital Dept., The Door and other Dolphin agencies

CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / February 25, 2026 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that it has received a determination letter from the Hearings Panel (the "Panel") of The Nasdaq Stock Market ("Nasdaq") dated February 23, 2026, notifying the Company that the Panel determined to delist the Company's securities from Nasdaq, due to the Company's failure to satisfy the continued listing conditions as previously disclosed. As a result, the Company securities will be suspended from trading at the open of business on February 26, 2026, and delisted from Nasdaq after the completion of certain applicable process. The Company does not intend to request a review of such decision.

Arizona Tribune - Boulevard (English)